1. Home
  2. BMR vs IRD Comparison

BMR vs IRD Comparison

Compare BMR & IRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMR
  • IRD
  • Stock Information
  • Founded
  • BMR 2009
  • IRD 2018
  • Country
  • BMR Israel
  • IRD United States
  • Employees
  • BMR N/A
  • IRD N/A
  • Industry
  • BMR Computer Software: Prepackaged Software
  • IRD
  • Sector
  • BMR Technology
  • IRD
  • Exchange
  • BMR Nasdaq
  • IRD NYSE
  • Market Cap
  • BMR 59.3M
  • IRD 62.0M
  • IPO Year
  • BMR 2023
  • IRD N/A
  • Fundamental
  • Price
  • BMR $3.35
  • IRD $1.02
  • Analyst Decision
  • BMR
  • IRD Strong Buy
  • Analyst Count
  • BMR 0
  • IRD 3
  • Target Price
  • BMR N/A
  • IRD $6.33
  • AVG Volume (30 Days)
  • BMR 1.0M
  • IRD 803.8K
  • Earning Date
  • BMR 08-05-2025
  • IRD 08-15-2025
  • Dividend Yield
  • BMR N/A
  • IRD N/A
  • EPS Growth
  • BMR N/A
  • IRD N/A
  • EPS
  • BMR N/A
  • IRD N/A
  • Revenue
  • BMR $3,064,000.00
  • IRD $13,651,000.00
  • Revenue This Year
  • BMR $21.21
  • IRD $51.41
  • Revenue Next Year
  • BMR N/A
  • IRD $68.84
  • P/E Ratio
  • BMR N/A
  • IRD N/A
  • Revenue Growth
  • BMR 5.33
  • IRD N/A
  • 52 Week Low
  • BMR $1.86
  • IRD $0.65
  • 52 Week High
  • BMR $6.59
  • IRD $2.18
  • Technical
  • Relative Strength Index (RSI)
  • BMR 59.12
  • IRD N/A
  • Support Level
  • BMR $2.98
  • IRD N/A
  • Resistance Level
  • BMR $3.20
  • IRD N/A
  • Average True Range (ATR)
  • BMR 0.22
  • IRD 0.00
  • MACD
  • BMR -0.01
  • IRD 0.00
  • Stochastic Oscillator
  • BMR 88.33
  • IRD 0.00

About BMR Beamr Imaging Ltd.

Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.

About IRD OPUS GENETICS INC

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes adeno-associated virus (AAV)-based gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA), and retinitis pigmentosa. The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist to reduce pupil size, and APX3330, a novel small-molecule inhibitor of Ref-1 to slow the progression of non-proliferative diabetic retinopathy.

Share on Social Networks: